坦韦克斯生物药厂获得博拉生物学,以在全球扩大生物学能力。 Tanvex BioPharma acquires Bora Biologics to expand biologics capabilities globally.

坦韦克斯生物制药公司收购了博拉生物制药公司的子公司波拉生物制药公司。 Tanvex BioPharma has acquired Bora Biologics, a subsidiary of Bora Pharmaceuticals. 这次合并将Tanvex在圣地亚哥生物类似药开发方面的专业知识与Bora在台湾的早期生物制剂能力结合起来. The merger combines Tanvex's expertise in biosimilar development in San Diego with Bora's early-stage biologics capabilities in Taiwan. 新实体以Bora Biologics为名运作,将为全球生物客户提供高效的端对端解决方案,在自己的品牌下维持Tanvex的生物类似产品系列。 Operating under the name Bora Biologics, the new entity will provide efficient end-to-end solutions for biologics clients globally, maintaining Tanvex's biosimilar product line under its own brand.